Experts call for greener pharmaceutical approvals

The procedures for authorising sales of pharmaceutical products in the EU should take into account the environmental risks posed by these products, according to a technical report published by the European Environment Agency (EEA) on Wednesday.

The full text of this article is only available to subscribers and free trialists. To login,please enter your email address and subscriber access code below.

Not a subscriber or free trialist? Why not take a free 14 day trial or subscribe today!

Having trouble logging in? Please contact our helpdesk

Back to top Back to top